Merry Christmas and Happy New Year
Thank you for being part of Microviable family and joining us so we can continue to grow. We wish you the best for the next holiday season and a great start of the new year!!
Meet our research intern Evelyn Villegas
Microviable wants to introduce you our research intern Evelyn Villegas, who has completed Higher Level Professional Training practices in Multiplatform Application Development in the bioinformatics area. Evelyn has also a degree from Law school and [...]
New GutAlive®, the anaerobic microbiome collection kit
Checkout our new GutAlive® !! The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. GutAlive® preserves the [...]
Microviable Therapeutics welcomes Marta Fernández on board.
Marta has a degree in Biology (2014) and a Food Biotechnology Master (2016) at the University of Oviedo, plus a MS in Microbiota, Probiotics and Prebiotics at the European University at Madrid (2021) with MS [...]
Borja Sánchez, co-founder of Microviable Therapeutics, among the 62 most influential scientists.
Asturias has 62 scientists among the most influential in the world. This has been revealed by the latest and prestigious Stanford ranking, which includes the 200,000 researchers -195,605 to be exact- most cited internationally in [...]
Microviable will be attending Bio-Europe 2022
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending BIO-Europe event in Leipzig, Germany, from October 24th to 26th. BIO-Europe® is the preeminent partnering conference for the [...]
Microviable welcomes Pilar Manrique, PhD on board
Welcome Pilar Manrique, PhD on board. Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018). Pilar has worked over ten years studying the [...]
Microviable Therapeutics will be presenting at AIMID 2022 Meeting
Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]
Microviable Therapeutics welcomes our research intern Carlos Martínez.
Meet our research intern Carlos Martínez, who is working with us on his Master´s Thesis as part of the Microbiota, Probiotics and Prebiotics Master from the European University of Madrid.
Microviable will be attending AIMID 2022 (I Asturias International Meeting on Clinical Microbiology and Infectious Disease).
Microviable Therapeutics will participate and sponsor of AIMID 2022 (I Asturias International Meeting on Clinical Microbiology and Infectious Disease) that will take place in Oviedo (Asturias) on September 22-23, 2022. Microviable is honored to become [...]